Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000812295-02-000033
Filing Date
2002-02-11
Accepted
2002-02-11 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 cellegy1.txt SC 13G/A 9425
  Complete submission text file 0000812295-02-000033.txt   11414
Mailing Address 100 FILLMORE STREET SUITE 300 DENVER CO 80206-4923
Business Address 100 FILLMORE STREET SUITE 300 DENVER CO 80206-4923 3033333863
JANUS CAPITAL CORP (Filed by) CIK: 0000812295 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
SIC: 0000

Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45279 | Film No.: 02534490
SIC: 2834 Pharmaceutical Preparations